The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 65, Issue 1, Pages 88-97
Publisher
Wiley
Online
2012-09-23
DOI
10.1002/art.37707
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients
- (2012) Athina Pyrpasopoulou et al. Molecular Diagnosis & Therapy
- Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response
- (2011) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
- (2011) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of the PTPN22 gene polymorphism with autoantibody positivity in Turkish rheumatoid arthritis patients
- (2011) A. Ates et al. TISSUE ANTIGENS
- Synovial Tissue Heterogeneity and Peripheral Blood Biomarkers
- (2011) Serena Bugatti et al. Current Rheumatology Reports
- Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: A meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein
- (2010) Diane van der Woude et al. ARTHRITIS AND RHEUMATISM
- Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis
- (2010) Ariana Montes et al. ARTHRITIS AND RHEUMATISM
- The late news on baff in autoimmune diseases
- (2010) Pierre Youinou et al. AUTOIMMUNITY REVIEWS
- A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis
- (2009) B. Skinningsrud et al. ANNALS OF THE RHEUMATIC DISEASES
- New ELISA for B Cell-Activating Factor
- (2009) L. Le Pottier et al. CLINICAL CHEMISTRY
- Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis
- (2009) L. Quartuccio et al. RHEUMATOLOGY
- A haplotype in STAT4 gene associated with rheumatoid arthritis in Caucasians is not associated in the Han Chinese population, but with the presence of rheumatoid factor
- (2009) Hua Li et al. RHEUMATOLOGY
- Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
- (2009) Maria Rehnberg et al. ARTHRITIS RESEARCH & THERAPY
- The BLyS Family: Toward a Molecular Understanding of B Cell Homeostasis
- (2008) John F. Treml et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Unknown
- (2008) Hye-Soon Lee et al. MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now